{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:55:16Z","timestamp":1788224116028,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ajem.2022.03.023","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T20:26:47Z","timestamp":1647635207000},"page":"171-177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Distinguishing characteristics of exposure to biguanide and sulfonylurea anti-diabetic medications in the United States"],"prefix":"10.1016","volume":"56","author":[{"given":"Omid","family":"Mehrpour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Saeedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Hoyte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Hadianfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaneh","family":"Nakhaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Brent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajem.2022.03.023_bb0005","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1067\/mem.2001.114314","article-title":"Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment","volume":"38","author":"Harrigan","year":"2001","journal-title":"Ann Emerg Med"},{"issue":"5","key":"10.1016\/j.ajem.2022.03.023_bb0010","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ajem.2005.05.001","article-title":"2004 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System","volume":"23","author":"Watson","year":"2005","journal-title":"Am J Emerg Med"},{"issue":"9","key":"10.1016\/j.ajem.2022.03.023_bb0015","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199602293340906","article-title":"Metformin","volume":"334","author":"Bailey","year":"1996","journal-title":"N Engl J Med"},{"issue":"11\u221212","key":"10.1016\/j.ajem.2022.03.023_bb0020","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1177\/0885066618793385","article-title":"Review of Biguanide (metformin) toxicity","volume":"34","author":"Wang","year":"2019","journal-title":"J Intensive Care Med"},{"issue":"4","key":"10.1016\/j.ajem.2022.03.023_bb0025","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00002018-199411040-00002","article-title":"Comparative tolerability profiles of oral antidiabetic agents","volume":"11","author":"Krentz","year":"1994","journal-title":"Drug Saf"},{"issue":"4","key":"10.1016\/j.ajem.2022.03.023_bb0030","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1464-5491.1999.00006.x","article-title":"Metformin-associated lactic acidosis: a rare or very rare clinical entity?","volume":"16","author":"Chan","year":"1999","journal-title":"Diabet Med"},{"issue":"10","key":"10.1016\/j.ajem.2022.03.023_bb0035","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2146\/ajhp050500","article-title":"Toxicology of oral antidiabetic medications","volume":"63","author":"Spiller","year":"2006","journal-title":"Am J Health Syst Pharm"},{"issue":"9","key":"10.1016\/j.ajem.2022.03.023_bb0040","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3109\/15563650.2012.734626","article-title":"Octreotide for the treatment of sulfonylurea poisoning","volume":"50","author":"Glatstein","year":"2012","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.ajem.2022.03.023_bb0045","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2337\/diacare.15.6.755","volume":"15","author":"Bailey","year":"1992","journal-title":"Biguanides and NIDDM Diabetes care"},{"issue":"12","key":"10.1016\/j.ajem.2022.03.023_bb0050","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1080\/15563650.2020.1834219","article-title":"2019 annual report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 37th annual report","volume":"58","author":"Gummin","year":"2020","journal-title":"Clin Toxicol (Phila)"},{"issue":"8","key":"10.1016\/j.ajem.2022.03.023_bb0055","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/(SICI)1096-9136(199808)15:8<651::AID-DIA628>3.0.CO;2-A","article-title":"Effect of metformin on bile salt circulation and intestinal motility in type 2 diabetes mellitus","volume":"15","author":"Scarpello","year":"1998","journal-title":"Diabet Med"},{"issue":"3","key":"10.1016\/j.ajem.2022.03.023_bb0060","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/15563659609013787","article-title":"Five year retrospective evaluation of sulfonylurea ingestion in children","volume":"34","author":"Quadrani","year":"1996","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1016\/j.ajem.2022.03.023_bb0065","first-page":"3868051","article-title":"Severe metformin poisoning successfully treated with simultaneous Venovenous hemofiltration and prolonged intermittent hemodialysis","volume":"2018","author":"Leonaviciute","year":"2018","journal-title":"Case Rep Crit Care"},{"issue":"6","key":"10.1016\/j.ajem.2022.03.023_bb0070","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/jdi.12328","article-title":"New mechanisms of metformin action: focusing on mitochondria and the gut","volume":"6","author":"Hur","year":"2015","journal-title":"Journal of Diabetes Investigation"},{"issue":"4","key":"10.1016\/j.ajem.2022.03.023_bb0075","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00592-016-0836-2","article-title":"Dose-related effects of metformin on acid-base balance and renal function in patients with diabetes who develop acute renal failure: a cross-sectional study","volume":"53","author":"Cucchiari","year":"2016","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.ajem.2022.03.023_bb0080","first-page":"Cd002967","article-title":"Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus","volume":"1","author":"Salpeter","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ajem.2022.03.023_bb0085","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0735-6757(97)90073-5","article-title":"Metformin overdose","volume":"15","author":"Brady","year":"1997","journal-title":"Am J Emerg Med"},{"issue":"5725","key":"10.1016\/j.ajem.2022.03.023_bb0090","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/bmj.3.5725.752","article-title":"Fatal self-poisoning with phenformin","volume":"3","author":"Bingle","year":"1970","journal-title":"Br Med J"},{"issue":"2","key":"10.1016\/j.ajem.2022.03.023_bb0095","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/bja\/ael347","article-title":"Severe lactic acidosis and rhabdomyolysis following metformin and ramipril overdose","volume":"98","author":"Galea","year":"2007","journal-title":"Br J Anaesth"},{"issue":"8","key":"10.1016\/j.ajem.2022.03.023_bb0100","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/PEC.0000000000000517","article-title":"Lacticemia after acute overdose of metformin in an adolescent managed without intravenous sodium bicarbonate or extracorporeal therapy","volume":"31","author":"Bebarta","year":"2015","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.ajem.2022.03.023_bb0105","doi-asserted-by":"crossref","unstructured":"Fatima, M., S. Sadeeqa, ASNazir, Metformin and its gastrointestinal problems: A review: Biomedical Research, 2018. 29.","DOI":"10.4066\/biomedicalresearch.40-18-526"},{"issue":"4","key":"10.1016\/j.ajem.2022.03.023_bb0110","first-page":"473","volume":"19","author":"Bonnet","year":"2017","journal-title":"Understanding and overcoming metformin gastrointestinal intolerance"},{"issue":"5","key":"10.1016\/j.ajem.2022.03.023_bb0115","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/ndt\/12.5.1046","article-title":"Bicarbonate haemodialysis as a treatment of metformin overdose","volume":"12","author":"Heaney","year":"1997","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1016\/j.ajem.2022.03.023_bb0120","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1046\/j.1365-2044.1998.436-az0549.x","article-title":"The management of metformin overdose","volume":"53","author":"Teale","year":"1998","journal-title":"Anaesthesia"},{"issue":"8","key":"10.1016\/j.ajem.2022.03.023_bb0125","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1515\/jpem-2001-0814","article-title":"Gliclazide-induced hepatitis, hemiplegia and dysphasia in a suicide attempt","volume":"14","author":"Caksen","year":"2001","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ajem.2022.03.023_bb0130","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0736-4679(98)00103-6","article-title":"Phenformin and lactic acidosis: a case report and review","volume":"16","author":"Kwong","year":"1998","journal-title":"J Emerg Med"},{"issue":"6","key":"10.1016\/j.ajem.2022.03.023_bb0135","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2337\/diacare.15.6.755","article-title":"Biguanides and NIDDM","volume":"15","author":"Bailey","year":"1992","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.ajem.2022.03.023_bb0140","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1515\/cclm-2014-0208","article-title":"Acute metformin intoxication: 2012 experience of emergency Departement of Lodi, Italy","volume":"52","author":"Acquistapace","year":"2014","journal-title":"Clin Chem Lab Med"},{"issue":"9","key":"10.1016\/j.ajem.2022.03.023_bb0145","doi-asserted-by":"crossref","first-page":"1721.e1","DOI":"10.1016\/j.ajem.2018.05.072","article-title":"Hemodialysis in metformin-associated lactic acidosis due to acute overdose in a metformin-na\u00efve patient","volume":"36","author":"McCabe","year":"2018","journal-title":"Am J Emerg Med"},{"issue":"1","key":"10.1016\/j.ajem.2022.03.023_bb0150","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1038\/ncomms6116","article-title":"Optical control of insulin release using a photoswitchable sulfonylurea","volume":"5","author":"Broichhagen","year":"2014","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ajem.2022.03.023_bb0155","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s13104-018-3404-8","article-title":"Unintentional sulfonylurea toxicity due to a drug\u2013drug interaction: a case report","volume":"11","author":"Gunaratne","year":"2018","journal-title":"BMC Res Notes"},{"issue":"3","key":"10.1016\/j.ajem.2022.03.023_bb0160","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0736-4679(98)00010-9","article-title":"Hemiparesis and Altered Mental Status in a Child After Glyburide Ingestion 11Toxicology is coordinated by Kenneth Kulig,MD, of Denver, Colorado","volume":"16","author":"Spiller","year":"1998","journal-title":"The Journal of Emergency Medicine"},{"issue":"2","key":"10.1016\/j.ajem.2022.03.023_bb0165","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5414\/CPP44051","article-title":"Antidiabetic medications in overdose: a comparison of the inquiries made to a regional poisons unit regarding original sulfonylureas, biguanides and insulin","volume":"44","author":"von Mach","year":"2006","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.ajem.2022.03.023_bb0170","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/bcpt.13273","article-title":"Metformin overdose: a serious iatrogenic complication-Western France poison control Centre data analysis","volume":"125","author":"Stevens","year":"2019","journal-title":"Basic Clin Pharmacol Toxicol"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675722001826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675722001826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:01:01Z","timestamp":1760025661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675722001826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":34,"alternative-id":["S0735675722001826"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2022.03.023","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinguishing characteristics of exposure to biguanide and sulfonylurea anti-diabetic medications in the United States","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2022.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}